Abstract:Abstract Cell signal networks are orchestrated directly or indirectly by various peptide-mediated protein–protein interactions, which are normally weak and transient and thus ideal for biological regulation and medicinal intervention. Here, we develop a general-purpose method for modeling and predicting the binding affinities of protein–peptide interactions (PpIs) at the structural level. The method is a hybrid strategy that employs an unsupervised approach to derive a layered PpI atom–residue interaction (ulPpI[a-r]) potential between different protein atom types and peptide residue types from thousands of solved PpI complex structures and then statistically correlates the potential descriptors with experimental affinities (KD values) over hundreds of known PpI samples in a supervised manner to create an integrated unsupervised–supervised PpI affinity (usPpIA) predictor. Although both the ulPpI[a-r] potential and usPpIA predictor can be used to calculate PpI affinities from their complex structures, the latter seems to perform much better than the former, suggesting that the unsupervised potential can be improved substantially with a further correction by supervised statistical learning. We examine the robustness and fault-tolerance of usPpIA predictor when applied to treat the coarse-grained PpI complex structures modeled computationally by sophisticated peptide docking and dynamics simulation. It is revealed that, despite developed solely based on solved structures, the integrated unsupervised–supervised method is also applicable for locally docked structures to reach a quantitative prediction but can only give a qualitative prediction on globally docked structures. The dynamics refinement seems not to change (or improve) the predictive results essentially, although it is computationally expensive and time-consuming relative to peptide docking. We also perform extrapolation of usPpIA predictor to the indirect affinity quantities of HLA-A*0201 binding epitope peptides and NHERF PDZ binding scaffold peptides, consequently resulting in a good and moderate correlation of the predicted KD with experimental IC50 and BLU on the two peptide sets, with Pearson’s correlation coefficients Rp = 0.635 and 0.406, respectively.

Predicting therapeutic and side effects from drug binding affinities to human proteome structures

Predicting Protein-Ligand Interactions Based on Bow-Pharmacological Space and Bayesian Additive Regression Trees

Prediction of Potential Toxicity and Side Effect Protein Targets of a Small Molecule by a Ligand–protein Inverse Docking Approach

Predicting Polypharmacology by Binding Site Similarity: From Kinases to the Protein Universe

Machine learning accelerates MD-based binding pose prediction between ligands and proteins

Relating drug–protein interaction network with drug side effects

A Novel Strategy for Prediction of Human Plasma Protein Binding Using Machine Learning Techniques

Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.

Pred-binding: large-scale protein–ligand binding affinity prediction

Predicting Drugs Side Effects Based on Chemical-Chemical Interactions and Protein-Chemical Interactions

A machine learning approach to predicting protein–ligand binding affinity with applications to molecular docking

Integrated unsupervised–supervised modeling and prediction of protein–peptide affinities at structural level

AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges

Leveraging nonstructural data to predict structures and affinities of protein-ligand complexes

Chemical-Protein Interactome and Its Application in Off-Target Identification

In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models

Highly accurate protein structure prediction for the human proteome

Machine learning approaches for predicting compounds that interact with therapeutic and ADMET related proteins.

Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions.

Docking-informed machine learning for kinome wide affinity prediction

How accurately can one predict drug binding modes using AlphaFold models?